Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 138 for virus
Company Exchange Symbol Last price Quote change Market cap
Merck & Co., Inc. NYSE MRK 64.97 +0.42 (0.65%) 179.12B
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and ...
Advanced Viral Research (Inactive) OTCMKTS ADVR
... loss of appetite and lethargy experienced by patients with advanced malignant cancer, human immunodeficiency virus-acquired immune deficiency syndrome ...
Viral Response Systems (Inactive) OTCMKTS VRSI
Viral Response Systems manufactures and markets the Viralizer, a portable electric apparatus which applies controlled heat and medicants to the nose, mouth ...
Luminex Corporation NASDAQ LMNX 20.19 -0.09 (-0.44%) 887.31M
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life ...
VIRAL SYNTEX LTD. BOM 526171 0.00
Novavax, Inc. NASDAQ NVAX 1.01 -0.01 (-0.98%) 285.44M
The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), ...
Response Biomedical Corp TSE RBM 0.00000
Response Biomedical Corp. (Response) offers diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental ...
MERCK AND CO INC EPA MRK 57.74 +1.36 (2.41%)
Response Biomedical Corp (ADR) OTCBB RPBIF 0.0000 9.04M
Response Biomedical Corp. (Response) offers diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental ...
MERCK CO. DL-,01 FRA 6MK 58.25 +1.76 (3.11%)
ERBA Diagnostics Inc OTCMKTS ERBA 0.270 0.000 (0.00%) 22.04M
ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures and markets diagnostic test kits, or assays, and automated systems that are used to aid ...
Voyager Therapeutics Inc NASDAQ VYGR 9.19 -0.17 (-1.82%) 250.25M
The Company's clinical candidate, VY-AADC01, is an adeno-associated virus ( AAV) gene therapy product candidate, for the treatment of advanced Parkinson's ...
MERCK & CO INC BVMF MRCK34 209.60 0.00 (0.00%)
LUMINEX CORP. DEL DL-,01 FRA LMX 17.77 -0.11 (-0.63%)
Merck & Co SWX MRK 67.00 0.00 (0.00%)
Atara Biotherapeutics Inc NASDAQ ATRA 14.60 -0.75 (-4.89%) 429.19M
T-cells are a type of white blood cell. The Company's product candidate, ATA129, is a third-party derived Epstein-Barr virus CTL for the treatment of Epstein-Barr ...
RESPONSE BIOMEDICAL FRA RBQP 0.759
Spring Bank Pharmaceuticals Inc NASDAQ SBPH 13.46 +1.46 (12.18%) 126.79M
... of the STimulator of INterferon Genes (STING) pathway. The Company focuses on developing SB 9200 for the treatment of chronic hepatitis B virus (HBV).
ERBA DIAGNOSTICS DL-,01 FRA IV1 0.426
NOVAVAX INC. DL-,01 FRA NVV 0.895 +0.002 (0.22%)